Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Antiviral Therapy
|
August 9, 2014
Safety, pharmacokinetics and pharmacodynamics of the oral toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C
Eric Lawitz, Daniel Gruener, Thomas Marbury, et al.
Clinical and Translational Science
|
July 25, 2018
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy
Hwa-Ping Feng, Zifang Guo, Luzelena Caro, et al.
Journal of Hepatology
|
January 7, 2015
A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection
Tarek Hassanein, Karen D Sims, Michael Bennett, et al.
Clinical and Translational Science
|
July 25, 2018
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy
Hwa-Ping Feng, Zifang Guo, Luzelena Caro, et al.
Journal of Personalized Medicine
|
December 15, 2018
The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018
Sophie Visvikis-Siest, Vesna Gorenjak, Maria G Stathopoulou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 17, 2015
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients
Gregory T Everson, Karen D Sims, Paul J Thuluvath, et al.
Diabetes
|
March 10, 2012
A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control
Vinay Bhaskar, Ira D Goldfine, Daniel H Bedinger, et al.
Plos One
|
February 18, 2014
Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity
John A Corbin, Vinay Bhaskar, Ira D Goldfine, et al.
Mabs
|
January 16, 2014
Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: a potential new approach for the treatment of hyperinsulinemic hypoglycemia
John A Corbin, Vinay Bhaskar, Ira D Goldfine, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Antiviral Therapy
|
August 9, 2014
Safety, pharmacokinetics and pharmacodynamics of the oral toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C
Eric Lawitz, Daniel Gruener, Thomas Marbury, et al.
Clinical and Translational Science
|
July 25, 2018
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy
Hwa-Ping Feng, Zifang Guo, Luzelena Caro, et al.
Journal of Hepatology
|
January 7, 2015
A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection
Tarek Hassanein, Karen D Sims, Michael Bennett, et al.
Clinical and Translational Science
|
July 25, 2018
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy
Hwa-Ping Feng, Zifang Guo, Luzelena Caro, et al.
Journal of Personalized Medicine
|
December 15, 2018
The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018
Sophie Visvikis-Siest, Vesna Gorenjak, Maria G Stathopoulou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 17, 2015
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients
Gregory T Everson, Karen D Sims, Paul J Thuluvath, et al.
Diabetes
|
March 10, 2012
A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control
Vinay Bhaskar, Ira D Goldfine, Daniel H Bedinger, et al.
Plos One
|
February 18, 2014
Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity
John A Corbin, Vinay Bhaskar, Ira D Goldfine, et al.
Mabs
|
January 16, 2014
Inhibition of insulin receptor function by a human, allosteric monoclonal antibody: a potential new approach for the treatment of hyperinsulinemic hypoglycemia
John A Corbin, Vinay Bhaskar, Ira D Goldfine, et al.
Page
of 8